Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 2
1984 2
1985 3
1986 5
1987 5
1988 2
1989 4
1990 5
1991 5
1992 5
1993 5
1994 4
1995 2
1996 2
1997 1
1998 2
1999 3
2000 6
2001 2
2002 3
2003 4
2004 2
2005 6
2006 7
2007 6
2008 7
2009 6
2010 10
2011 13
2012 12
2013 7
2014 11
2015 9
2016 17
2017 10
2018 18
2019 12
2020 6
2021 8
2022 18
2023 10
2024 11
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

253 results

Results by year

Filters applied: . Clear all
Page 1
Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes.
Gerstein HC, Sattar N, Rosenstock J, Ramasundarahettige C, Pratley R, Lopes RD, Lam CSP, Khurmi NS, Heenan L, Del Prato S, Dyal L, Branch K; AMPLITUDE-O Trial Investigators. Gerstein HC, et al. N Engl J Med. 2021 Sep 2;385(10):896-907. doi: 10.1056/NEJMoa2108269. Epub 2021 Jun 28. N Engl J Med. 2021. PMID: 34215025 Free article. Clinical Trial.
Lipoedema.
Andersen MT, Burian EA, Nissen CV, Rungby J, Karlsmark T. Andersen MT, et al. Among authors: rungby j. Ugeskr Laeger. 2022 Dec 19;184(51):V04220244. Ugeskr Laeger. 2022. PMID: 36621873 Free article. Review. Danish.
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome.
Pfeffer MA, Claggett B, Diaz R, Dickstein K, Gerstein HC, Køber LV, Lawson FC, Ping L, Wei X, Lewis EF, Maggioni AP, McMurray JJ, Probstfield JL, Riddle MC, Solomon SD, Tardif JC; ELIXA Investigators. Pfeffer MA, et al. N Engl J Med. 2015 Dec 3;373(23):2247-57. doi: 10.1056/NEJMoa1509225. N Engl J Med. 2015. PMID: 26630143 Free article. Clinical Trial.
Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial.
Dormandy JA, Charbonnel B, Eckland DJ, Erdmann E, Massi-Benedetti M, Moules IK, Skene AM, Tan MH, Lefèbvre PJ, Murray GD, Standl E, Wilcox RG, Wilhelmsen L, Betteridge J, Birkeland K, Golay A, Heine RJ, Korányi L, Laakso M, Mokán M, Norkus A, Pirags V, Podar T, Scheen A, Scherbaum W, Schernthaner G, Schmitz O, Skrha J, Smith U, Taton J; PROactive Investigators. Dormandy JA, et al. Lancet. 2005 Oct 8;366(9493):1279-89. doi: 10.1016/S0140-6736(05)67528-9. Lancet. 2005. PMID: 16214598 Free article. Clinical Trial.
Characterization of genetic variants of GIPR reveals a contribution of β-arrestin to metabolic phenotypes.
Kizilkaya HS, Sørensen KV, Madsen JS, Lindquist P, Douros JD, Bork-Jensen J, Berghella A, Gerlach PA, Gasbjerg LS, Mokrosiński J, Mowery SA, Knerr PJ, Finan B, Campbell JE, D'Alessio DA, Perez-Tilve D, Faas F, Mathiasen S, Rungby J, Sørensen HT, Vaag A, Nielsen JS, Holm JC, Lauenborg J, Damm P, Pedersen O, Linneberg A, Hartmann B, Holst JJ, Hansen T, Wright SC, Lauschke VM, Grarup N, Hauser AS, Rosenkilde MM. Kizilkaya HS, et al. Among authors: rungby j. Nat Metab. 2024 Jul;6(7):1268-1281. doi: 10.1038/s42255-024-01061-4. Epub 2024 Jun 13. Nat Metab. 2024. PMID: 38871982 Free PMC article.
In Alzheimer's Disease, 6-Month Treatment with GLP-1 Analog Prevents Decline of Brain Glucose Metabolism: Randomized, Placebo-Controlled, Double-Blind Clinical Trial.
Gejl M, Gjedde A, Egefjord L, Møller A, Hansen SB, Vang K, Rodell A, Brændgaard H, Gottrup H, Schacht A, Møller N, Brock B, Rungby J. Gejl M, et al. Among authors: rungby j. Front Aging Neurosci. 2016 May 24;8:108. doi: 10.3389/fnagi.2016.00108. eCollection 2016. Front Aging Neurosci. 2016. PMID: 27252647 Free PMC article.
Glucagon augments the secretion of FGF21 and GDF15 in MASLD by indirect mechanisms.
Richter MM, Kemp IM, Heebøll S, Winther-Sørensen M, Kjeldsen SAS, Jensen NJ, Nybing JD, Linden FH, Høgh-Schmidt E, Boesen MP, Madsbad S, Schiødt FV, Nørgaard K, Schmidt S, Gluud LL, Haugaard SB, Holst JJ, Nielsen S, Rungby J, Wewer Albrechtsen NJ. Richter MM, et al. Among authors: rungby j. Metabolism. 2024 Jul;156:155915. doi: 10.1016/j.metabol.2024.155915. Epub 2024 Apr 16. Metabolism. 2024. PMID: 38631460 Free article.
GLP-1 and Amylin in the Treatment of Obesity.
Jorsal T, Rungby J, Knop FK, Vilsbøll T. Jorsal T, et al. Among authors: rungby j. Curr Diab Rep. 2016 Jan;16(1):1. doi: 10.1007/s11892-015-0693-3. Curr Diab Rep. 2016. PMID: 26699764 Review.
DD2 - nye veje i behandlingen af type 2-diabetes.
Nielsen JS, Rungby J, Christiansen JS, Vaag A, Friborg S, Sørensen HT, Beck-Nielsen H. Nielsen JS, et al. Among authors: rungby j. Ugeskr Laeger. 2014 Jun 2;176(11A):V66222. Ugeskr Laeger. 2014. PMID: 25186673 Free article. Danish. No abstract available.
253 results